Additionally, analogues of apelin have been developed to target cardiovascular disease, with reports of beneficial effects on myocardial dysfunction and hypertension in rats.83,84 These molecules have been reviewed in detail elsewhere,77,85 and the current report will focus on apelin analogue advantages in diabetes. This evidence concerns the gene APLN and hypertensive disorder.